News & Events about Inmune Bio Inc.
Boca Raton, Florida, Jan. 25, 2023 (GLOBE NEWSWIRE) -- INmune Bio, Inc.(NASDAQ: INMB) (the Company), a clinical-stage immunology company focused on developing treatments that harness the patients innate immune system to fight disease, in collaboration with Professor Armando Villalta, Ph.D. of ...
XPro1595 decreases development of amyloid beta and tau following TBI in murine model of Alzheimers disease Boca Raton, Florida, Dec. 22, 2022 (GLOBE NEWSWIRE) -- INmune Bio, Inc.(NASDAQ: INMB) (the Company), a clinical-stage immunology company focused on developing treatments that harness the ...
Boca Raton, Florida, Dec. 08, 2022 (GLOBE NEWSWIRE) -- INmuneBio, Inc.(NASDAQ: INMB) (INMB or the Company), a clinical-stage immunology company focused ondeveloping treatments that harness the patients innate immune system to fight disease will present data from UK patients with MDS or AML treated ...
Globe Newswire
2 months ago
INmuneBio, a leader in novel therapies and innovative trial design for AD participates in 15thCTAD conference in San Francisco November 29th to December 2nd Boca Raton, Florida, Nov. 29, 2022 (GLOBE NEWSWIRE) -- INmuneBio, Inc.(NASDAQ: INMB) (the Company), a clinical-stage immunology company focused...
Globe Newswire
2 months ago
BOCA RATON, FL., Nov. 14, 2022 (GLOBE NEWSWIRE) -- INmuneBio, Inc.(NASDAQ: INMB) (the Company), a clinical-stage immunology company focused on developing treatments that harness the patients innate immune system to fight disease, today announces that Health Canada has issued the Company a No ...